Analyse de l'application CardioRisk Calculator pour le 14 janvier

CardioRisk Calculator™ simplifies cardiovascular risk stratification and is a Canadian dyslipidemia guidelines application. CardioRisk Calculator™ provides: -quick calculations on % LDL-C reductions -concise drug dosage information -clear snapshot of a patient's CV risk -options to bring lipid levels to target -easy identification of familial hypercholesterolemia This application has been developed with the ultimate goal of educating physicians on the most recent Canadian dyslipidemia guidelines and guidelines for the diagnosis of familial hypercholesterolemia. Programming support for the CardioRisk Calculator™ was provided through unrestricted grants to support the CardioRisk Clinic from the following (in alphabetical order): - Amgen Canada - Bayer Inc - Boehringer Ingelheim (Canada) Ltd - FH Canada - HLS Therapeutics - Janssen Inc - Novo Nordisk Canada - Sanofi Canada